Reconstructive surgical therapy of peri-implantitis bone defects
- Conditions
- Intraosseous peri-implant defectsOral Health
- Registration Number
- ISRCTN67095066
- Lead Sponsor
- Periocentrum Bilbao
- Brief Summary
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36802084/ (added 17/03/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 43
1. Show radiographically peri-implant intraosseous defects of at least 3mm depth.
2. Depth of clinical probing = 5mm with bleeding and/or suppuration.
3. Intra-surgically, the infra-osseous defect must have at least one intraosseous component of 3mm and a width of no more than 4mm.
4. The implant to be treated must have been in function for at least 12 months.
1. Has diabetes mellitus, hyperparathyroidism and/or osteomalacia.
2. Treated with corticosteroids.
3. Medicated with drugs that induce gingival hyperplasia.
4. Allergic to penicillin or who have taken antibiotics in the last 6 months.
5. Pregnant or breast-feeding patients.
6. Patients with osteoporosis.
7. Impossibility of stabilizing bovine bone with collagen or primary closure of soft tissue.
8. Patients with collagen allergy.
9. Patients treated with radiotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Probing depth (PS) is measured in 6 locations per implant. It consists of probing from the margin of the peri-implant mucosa to the most apical part of the peri-implant defect at baseline, at 6 months and at 12 months.
- Secondary Outcome Measures
Name Time Method